Home › Multiple Sclerosis › Michigan
Pag-aaral pangklinika para sa Multiple Sclerosis sa Michigan
10 pag-aaral para sa Multiple Sclerosis ang naghahanap ng mga kalahok sa mga site sa Michigan.
Mga Lungsod sa Michigan
Opisyal na teksto ng pag-aaral (English)
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- TG Therapeutics Investigational Trial Site, Ann Arbor
- TG Therapeutics Investigational Trial Site, Detroit
- TG Therapeutics Investigational Trial Site, Farmington
- at 2 pa
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06433752Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Michigan Institute for Neurological Disorders- Site Number : 8400004, Farmington Hills
Nagre-recruitPhase 3
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07325292RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- University of Michigan, Ann Arbor
- Henry Ford Health, Novi
Nagre-recruitPhase 2
Edad 18 hanggang 80 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT07002034A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity
- Northwest Neurology, Southfield
Nagre-recruitPhase 2
Edad 18 hanggang 70 · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06782490A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
- TG Therapeutics Investigational Trial Site, Ann Arbor
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06680037Privosegtor Investigation in Optic Neuropathies Efficacy Evaluation Research
- Kahana Oculoplastic and Orbital Surgery, Livonia
Nagre-recruitPhase 3
Edad 18 hanggang 50 · Lahat ng kasarian · Na-update Ago 14, 2026 · NCT07623668A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Michigan Institute of Neurological, Farmington Hills
Nagre-recruitPhase 3
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT07225504Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype
- University of Michigan, Ann Arbor
Nagre-recruitPhase 2
Edad 18 hanggang 65 · Lahat ng kasarian · Na-update Hul 17, 2026 · NCT05269628A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years
- Quest Research Institute, Farmington Hills
Nagre-recruitPhase 2
Edad 18 hanggang 55 · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT06735248Investigating the Effect of Ocrelizumab in African Americans and Caucasians With Relapsing Multiple Sclerosis
- Wayne State University, Detroit
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 60 · Lahat ng kasarian · Na-update Hun 6, 2022 · NCT04458688Mula sa ClinicalTrials.gov, na-kuha noong Set 30, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.